IP Library Granted Patent US 10,688,223
Granted Patent B2
US 10,688,223 · App. 15/650,397 · Granted Jun 23, 2020

Smart release system for growth factor delivery and combined bone and vascular growth

Inventors: Haitao Cui (Arlington, VA); Wei Zhu (Washington, DC); Benjamin Holmes (Washington, DC); Lijie Grace Zhang (Arlington, VA)
Assignee: The George Washington University, a Congressionally Chartered Not-for-Profit Corporation
A61L27/54A61F2/06A61F2/28A61K9/0024A61L27/28A61L27/34A61L27/56A61B17/00A61F2002/2817A61F2002/3092A61L31/00A61L2300/414A61L2420/04A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,688,223
App. No.
15/650,397
Granted
Jun 23, 2020
Kind
B2
Abstract

Embodiments of the present invention relate to structures and systems having a three-dimensional biomimetic structure with a porous biomimetic three-dimensional scaffold and a coating deposited onto a surface of the porous biomimetic three-dimensional scaffold as well as methods of using and fabricating the like.

Claims (17)

1. A three-dimensional biomimetic structure, comprising:

a porous biomimetic three-dimensional scaffold; and

a coating deposited onto a surface of the porous biomimetic three-dimensional scaffold,

wherein the coating comprises a polymer network comprising a first biocompatible polymer, a second biocompatible polymer, a biologically active agent, and a cleavable cross-linking chemical compound,

wherein each of the first biocompatible polymer and the second biocompatible polymer are reversibly cross-linked by the cleavable cross-linking chemical compound to each other or to the biologically active agent,

wherein the biologically active agent is cross-linked to the polymer network when the cleavable cross-linking chemical compound is in an un-cleaved conformation,

wherein the biologically active agent is releasable from the polymer network when the cleavable cross-linking chemical compound is in a cleaved conformation,

wherein the porous biomimetic three-dimensional scaffold defines a first internal channel extending along a first axis and a second internal channel extending along a second axis, and

wherein the first internal channel and the second internal channel intersect.

2. The three-dimensional biomimetic structure of claim 1 , wherein each of the first internal channel and the second internal channel has a diameter of between 100 μm to 1000 μm.

3. The three-dimensional biomimetic structure of claim 1 , wherein the cleavable cross-linking chemical compound is cleavable by an enzyme or catalyst.

4. The three-dimensional biomimetic structure of claim 1 , wherein the porous biomimetic three-dimensional scaffold comprises a biocompatible polymer.

5. The three-dimensional biomimetic structure of claim 1 , wherein the biologically active agent is a growth factor.

6. The three-dimensional biomimetic structure of claim 1 , wherein the coating further comprises a first layer and a second layer, wherein each of the first layer and the second layer comprises a polymer network comprising a first biocompatible polymer, a second biocompatible polymer, a biologically active agent, and a cleavable cross-linking chemical compound, and

wherein each of the first biocompatible polymer and the second biocompatible polymer are reversibly cross-linked by the cleavable cross-linking chemical compound to each other or to the biologically active agent.

7. The three-dimensional biomimetic structure of claim 6 , wherein the first layer comprises a first biologically active agent and the second layer comprises a second biologically active agent.

8. The three-dimensional biomimetic structure of claim 1 , wherein said first biocompatible polymer carries a charge, said second biocompatible polymer carries a charge, and wherein said charge of the first biocompatible polymer and said charge of the second biocompatible polymer are not the same.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 31, 2017
From: GEORGE WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044329/0111 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2017
From: CUI, HAITAO; ZHU, WEI; HOLMES, BENJAMIN; ZHANG, LIJIE GRACE
To: THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION
Reel/Frame 043010/0796 →
Continuity (2)
Provisional Application 62362427 · Jul 14, 2016
Related Publication 20180015207A1 · Jan 18, 2018
Cited By (1)
US 12,433,751